PARP1 and prostate cancer: We then investigated the possibility that cell necrosis mediated by the inhibition of PARP-1 concomitant with Ets-1 accumulation was due to an increase in DNA damage as observed with Ets fusion proteins in prostate cancer and Ewing's sarcoma [26], [30].